Literature DB >> 4031065

Diminished type I collagen synthesis and reduced alpha 1(I) collagen messenger RNA in cultured fibroblasts from patients with dominantly inherited (type I) osteogenesis imperfecta.

D W Rowe, J R Shapiro, M Poirier, S Schlesinger.   

Abstract

Type I osteogenesis imperfecta (OI) is characterized clinically by a moderate fracture frequency with minimal bone deformity and dominant inheritance. Previous studies of the collagenous proteins synthesized by dermal fibroblasts obtained from unrelated patients with this form of OI suggested that the biochemical basis of the disease was reduced production of type I collagen. This study was designed to determine if this biochemical finding segregated with the disease within an individual family. Dermal fibroblast strains were established from three generations of a family having the typical features of type I OI. Analysis of the collagenous proteins made in culture revealed an elevated alpha 1(III) to alpha 1(I) collagen type ratio and an elevated alpha 1(I) to alpha 2(I) collagen chain ratio. The procollagen that accumulated in the medium reflected these ratios to the same degree. Total collagen synthesis was significantly reduced in affected family members. Therefore, the most striking abnormality in affected members was a 50-75% reduction of type I collagen production. Furthermore, the ratio of the alpha 1(I)/alpha 2(I) collagen messenger RNA (mRNA), measured by dot hybridization, was one-half of the value of uninvolved family members and unrelated controls. Since the reduction in the production of type I collagen and the altered alpha 1(I)/alpha 2(I) mRNA ratio clearly segregated with affected individuals within this family, these biochemical measurements may be a useful genetic marker for type I OI.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4031065      PMCID: PMC423866          DOI: 10.1172/JCI112012

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  38 in total

1.  Osteogenesis imperfecta and Paget's disease of bone. Biochemical and morphologic studies.

Authors:  J R Shapiro; T Triche; D W Rowe; A Munabi; H S Cattell; S Schlesinger
Journal:  Arch Intern Med       Date:  1983-12

2.  Internal deletion in a collagen gene in a perinatal lethal form of osteogenesis imperfecta.

Authors:  M L Chu; C J Williams; G Pepe; J L Hirsch; D J Prockop; F Ramirez
Journal:  Nature       Date:  1983 Jul 7-13       Impact factor: 49.962

3.  The molecular defect in a nonlethal variant of osteogenesis imperfecta. Synthesis of pro-alpha 2(I) chains which are not incorporated into trimers of type I procollagen.

Authors:  S B Deak; A Nicholls; F M Pope; D J Prockop
Journal:  J Biol Chem       Date:  1983-12-25       Impact factor: 5.157

4.  Restriction fragment length polymorphism associated with the pro alpha 2(I) gene of human type I procollagen. Application to a family with an autosomal dominant form of osteogenesis imperfecta.

Authors:  P Tsipouras; J C Myers; F Ramirez; D J Prockop
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

5.  The mRNAs for the pro-alpha 1(I) and pro-alpha 2(I) chains of type I procollagen are translated at the same rate in normal human fibroblasts and in fibroblasts from two variants of osteogenesis imperfecta with altered steady state ratios of the two mRNAs.

Authors:  W J de Wet; M L Chu; D J Prockop
Journal:  J Biol Chem       Date:  1983-12-10       Impact factor: 5.157

6.  Synthesis of a shortened pro-alpha 2(I) chain and decreased synthesis of pro-alpha 2(I) chains in a proband with osteogenesis imperfecta.

Authors:  W J de Wet; T Pihlajaniemi; J Myers; T E Kelly; D J Prockop
Journal:  J Biol Chem       Date:  1983-06-25       Impact factor: 5.157

7.  A single-base change at a splice site in a beta 0-thalassemic gene causes abnormal RNA splicing.

Authors:  R Treisman; N J Proudfoot; M Shander; T Maniatis
Journal:  Cell       Date:  1982-07       Impact factor: 41.582

8.  Recovery of DNA fragments from gels by transfer to DEAE-paper in an electrophoresis chamber.

Authors:  D B Danner
Journal:  Anal Biochem       Date:  1982-09-01       Impact factor: 3.365

9.  Structure of a cDNA for the pro alpha 2 chain of human type I procollagen. Comparison with chick cDNA for pro alpha 2(I) identifies structurally conserved features of the protein and the gene.

Authors:  M P Bernard; J C Myers; M L Chu; F Ramirez; E F Eikenberry; D J Prockop
Journal:  Biochemistry       Date:  1983-03-01       Impact factor: 3.162

10.  Synthesis and processing of a type I procollagen containing shortened pro-alpha 1(I) chains by fibroblasts from a patient with osteogenesis imperfecta.

Authors:  C J Williams; D J Prockop
Journal:  J Biol Chem       Date:  1983-05-10       Impact factor: 5.157

View more
  25 in total

1.  Increased expression of the gene for the pro alpha 1(IV) chain of basement-membrane procollagen in cultured skin fibroblasts from two variants of osteogenesis imperfecta.

Authors:  T Pihlajaniemi; J McKeon; S Gay; R Gay; W J de Wet; J C Myers; D J Prockop
Journal:  Biochem J       Date:  1989-01-15       Impact factor: 3.857

2.  Segregation analysis of dominant osteogenesis imperfecta in Italy.

Authors:  M Mottes; L Cugola; N Cappello; P F Pignatti
Journal:  J Med Genet       Date:  1990-06       Impact factor: 6.318

3.  Collagen Accumulation in Osteosarcoma Cells lacking GLT25D1 Collagen Galactosyltransferase.

Authors:  Stephan Baumann; Thierry Hennet
Journal:  J Biol Chem       Date:  2016-07-11       Impact factor: 5.157

4.  Single base pair alterations as the predominant category of mutation in type I osteogenesis imperfecta.

Authors:  A J Brookes; B Sykes; E Solomon
Journal:  J Med Genet       Date:  1989-06       Impact factor: 6.318

5.  Osteogenesis imperfecta type IV. Biochemical confirmation of genetic linkage to the pro alpha 2(I) gene of type I collagen.

Authors:  R J Wenstrup; P Tsipouras; P H Byers
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

6.  Osteogenesis imperfecta type I is commonly due to a COL1A1 null allele of type I collagen.

Authors:  M C Willing; C J Pruchno; M Atkinson; P H Byers
Journal:  Am J Hum Genet       Date:  1992-09       Impact factor: 11.025

7.  Severe osteogenesis imperfecta in cyclophilin B-deficient mice.

Authors:  Jae Won Choi; Shari L Sutor; Lonn Lindquist; Glenda L Evans; Benjamin J Madden; H Robert Bergen; Theresa E Hefferan; Michael J Yaszemski; Richard J Bram
Journal:  PLoS Genet       Date:  2009-12-04       Impact factor: 5.917

8.  Frameshift mutation near the 3' end of the COL1A1 gene of type I collagen predicts an elongated Pro alpha 1(I) chain and results in osteogenesis imperfecta type I.

Authors:  M C Willing; D H Cohn; P H Byers
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

9.  A scoring system for the assessment of clinical severity in osteogenesis imperfecta.

Authors:  Mona S Aglan; Laila Hosny; Rasha El-Houssini; Sawsan Abdelhadi; Fadia Salem; Rokia A S Elbanna; Seham A Awad; Moushira E Zaki; Samia A Temtamy
Journal:  J Child Orthop       Date:  2012-02-08       Impact factor: 1.548

10.  Phenotypic variability and abnormal type I collagen unstable at body temperature in a family with mild dominant osteogenesis imperfecta.

Authors:  R Tenni; P Biglino; K Dyne; A Rossi; M Filocamo; F Pendola; P Brunelli; P Buttitta; C Borrone; G Cetta
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.